Cases filed in Delaware
Cases 81 - 90 of 105
RSS Feed | View as table | Sort by last update
Merz Pharmaceuticals LLC v. Par Pharmaceutical Inc. et al
as 1:2012cv01723
Plaintiff: Merz Pharmaceuticals LLC
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Merz Pharmaceuticals LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acura Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
as 1:2012cv01372
Plaintiff: Acura Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Acura Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc. et al
as 1:2012cv01123
Plaintiff: Avanir Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant: Avanir Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Watson Laboratories, Inc. We have downloadable decisions or orders for this case
as 1:2012cv00517
Plaintiff: Bayer Pharma AG, Bayer Intellectual Property GMBH and Bayer HealthCare Pharmaceuticals Inc.
Defendant: Watson Pharmaceuticals Inc., Watson Pharma Inc., Actavis Pharma Inc. and others
Cause Of Action: 35 U.S.C. § 271
AR Holding Company Inc. v. Par Pharmaceutical Inc.
as 1:2012cv00419
Plaintiff: AR Holding Company Inc.
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: AR Holding Company Inc.
Cause Of Action: 35 U.S.C. § 271
Horizon Pharma Inc. et al v. Par Pharmaceutical Companies Inc. et al
as 1:2012cv00393
Plaintiff: Horizon Pharma Inc. and Horizon Pharma USA Inc.
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant: Horizon Pharma USA Inc. and Horizon Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Alkermes Pharma Ireland Limited v. Par Pharmaceutical Inc.
as 1:2011cv01119
Plaintiff: Alkermes Pharma Ireland Limited
Defendant: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Avanir Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. et al
as 1:2011cv00705
Plaintiff: Avanir Pharmaceuticals Inc. , Avanir Holding Company and Center for Neurologic Study
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Counter_defendant: Avanir Holding Company , Avanir Pharmaceuticals Inc. and Center for Neurologic Study
Cause Of Action: 35 U.S.C. § 271
Elan Corporation PLC et al v. IntelliPharmaCeutics Corporation et al
as 1:2011cv00480
Plaintiff: Elan Corporation PLC and Elan Pharma International Ltd.
Defendant: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Somaxon Pharmaceuticals Inc. v. Par Pharmaceutical Inc. et al
as 1:2011cv00476
Plaintiff: Somaxon Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?